Ascentage Pharma Group International - American Depository SharesAscentage Pharma Group International - American Depository SharesAscentage Pharma Group International - American Depository Shares

Ascentage Pharma Group International - American Depository Shares

No trades
No trades

Compare with Ascentage Pharma Group International - American Depository Shares


Market capitalization
‪1.59 B‬USD
−2.26USD
‪−172.88 M‬USD
‪79.87 M‬USD
Beta (1Y)
2.02
Next report date
Report period
EPS estimate
Revenue estimate

Company info


CEO
Dajun Yang
Headquarters
Suzhou
Founded
2009
ISIN
US04390B1052
CUSIP
04390B105
FIGI
BBG01RJXM9C9
Identifiers
ISIN US04390B1052
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.